CoEHAR, No Tobacco Day 2024: youth in the spotlight

The meeting will be held on Thursday, May 30, at 8:30 AM in the Aula Magna of the Biological Tower at the University of Catania. The topics discussed will range from oral to sexual health, from sociology to marketing, from diagnosis to clinical treatment, also covering innovative solutions and new tools provided through the use of artificial intelligence.

Continue ReadingCoEHAR, No Tobacco Day 2024: youth in the spotlight

Behavioral Interventions can help smokers with diabetes quit with a greater likelihood of success. However, structured programs are needed

The results were included in the review "Behavioural therapy for people with diabetes who smoke: a scoping review," published in the Journal of Primary Care and Community Health: it is now clear that persons living with diabetes are not the subject of targeted treatments and that there is ample room for progress. It seems that more structured and intensive therapies could benefit these persons in bidding farewell to cigarette smoking, while little is still known about the possible benefits of combining  behavioral therapies and nicotine replacement pharmacological therapies.

Continue ReadingBehavioral Interventions can help smokers with diabetes quit with a greater likelihood of success. However, structured programs are needed

HOW TO CHANGE HEALTH POLICY STRATEGIES? SMOPHED STUDY: INVESTIGATION ON VAPERS AND SMOKERS ACCESSING EMERGENCY HOSPITAL SERVICES.

But how much would harm reduction and the reduction of smoking-related diseases affect international health policy strategies? Would there be fewer hospital admissions without conventional cigarette smoke? The answer will be provided by questionnaires administered to over 3000 hospitalized patients whose smoking habits and potential use of non-combustion products will be analyzed to assess the causes of hospital admission and the subsequent outcomes of the diseases identified.

Continue ReadingHOW TO CHANGE HEALTH POLICY STRATEGIES? SMOPHED STUDY: INVESTIGATION ON VAPERS AND SMOKERS ACCESSING EMERGENCY HOSPITAL SERVICES.

International Young Researcher Awards Ceremony at CoEHAR, University of Catania, Italy

Dr. Nikolina Kastratovic of the Faculty of Medical Sciences at the University of Kragujevac, Serbia, was honored with the award for her outstanding project on the immunomodulatory effects of combustible and electronic cigarettes on human cells.

Continue ReadingInternational Young Researcher Awards Ceremony at CoEHAR, University of Catania, Italy

New report from The Royal College of Physician: positive impact of E-Cigarettes

The Royal College of Physicians has assessed the available evidence on the use of e-cigarettes, from health effects to the issue of youth vaping, publishing a report with over 50 recommendations. It concluded that e-cigarettes represent a valuable aid in smoking cessation, but that much more can and should be done to reduce their appeal, availability and affordability to people who do not smoke, including children and young people, and reduce environmental harms. 

Continue ReadingNew report from The Royal College of Physician: positive impact of E-Cigarettes

CoEHAR Founder Riccardo Polosa adresses the Australian Senators on vaping reform

According to the studies, “CoEHAR research in patients with COPD patients, asthma, high blood pressure, schizophrenia show clear benefits with objective evidence for harm reversal after switching from smoking.. and also showed that lung function and respiratory symptoms and muco-ciliary clearance improve after switching from smoking to vaping”.

Continue ReadingCoEHAR Founder Riccardo Polosa adresses the Australian Senators on vaping reform

CoEHAR welcomes the International partners of Replica

“We would like to thank all the partners for accepting to continue this important partnership with the new edition of the Replica Project” stated Prof. Giovanni Li Volti, recently reconfirmed COEHAR Director “The goal for this new session of experiments is to replicate published scientific works dealing with the impact of cigarette smoke and RRP on the progression of cancer and in particular to molecular mechanisms of chemoresistance. In particular, the result of such studies will make also the difference in terms of harm reduction strategies for a particular vulnerable population of patients and improve the quality of their life in terms of life expectancy and adverse reactions to chemotherapy”

Continue ReadingCoEHAR welcomes the International partners of Replica

MAGNIFICAT: published the innovative protocol on dual users and harm reduction potential

The MAGNIFICAT study, strongly advocated by Prof. Riccardo Polosa, will evaluate the effects of the combined use of conventional cigarettes and electronic cigarettes on human health, quantifying this impact by collecting samples, researching and describing the core of different levels of dual use on exposure to toxic substances and harm reduction, and using specific biomarkers, clinical endpoints, and behavioral correlations

Continue ReadingMAGNIFICAT: published the innovative protocol on dual users and harm reduction potential